KURA: Bair Teresa Brophy discloses a sale

By AlphaYouPublished Sep 29, 2026Form 4

Stocks in this disclosure

Reported activity

Bair Teresa Brophy

Reporting filer

Bair Teresa Brophy reported Sale in Kura Oncology, Inc.: 8442 units of Common Stock, dated 2026-09-28. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 29, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Bair Teresa Brophy	2026-09-28	S	Sale	8442	10.4973	187,002	1 day	Filed terms security Title: Common Stock transaction Date: 2026-09-28 transaction Form Type: 4 transaction Code: S equity Swap Involved: false id: F1 transaction Shares: 8442 transaction Price Per Share: 10.4973 transaction Acquired Disposed Code: D shares Owned Following Transaction: 187002 direct Or Indirect Ownership: D

Common Stock

Owner: Bair Teresa Brophy
Date: 2026-09-28
Code: S
Action: Sale
Quantity: 8442
Price: 10.4973
Following holdings: 187,002
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-28
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Shares: 8442
transaction Price Per Share: 10.4973
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 187002
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Bair Teresa Brophy: Chief Legal Officer.
The filing reports a Rule 10b5-1 trading plan.
F1: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The one-year anniversary of the specified development milestone was determined to be met on September 27, 2026, resulting in the vesting of 1/6th of the underlying shares.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Bair Teresa Brophy

2026-09-28

Sale

8442

10.4973

187,002

1 day

Filed terms

security Title: Common Stock
transaction Date: 2026-09-28
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Shares: 8442
transaction Price Per Share: 10.4973
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 187002
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Bair Teresa Brophy: Chief Legal Officer.

The filing reports a Rule 10b5-1 trading plan.

F1: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The one-year anniversary of the specified development milestone was determined to be met on September 27, 2026, resulting in the vesting of 1/6th of the underlying shares.